CERO
Price
$7.72
Change
-$0.14 (-1.78%)
Updated
Aug 26, 04:59 PM (EDT)
Capitalization
10M
UTHR
Price
$309.32
Change
+$3.94 (+1.29%)
Updated
Aug 26, 04:59 PM (EDT)
Capitalization
13.81B
64 days until earnings call
Interact to see
Advertisement

CERO vs UTHR

Header iconCERO vs UTHR Comparison
Open Charts CERO vs UTHRBanner chart's image
CERO Therapeutics Holdings
Price$7.72
Change-$0.14 (-1.78%)
Volume$100
Capitalization10M
United Therapeutics
Price$309.32
Change+$3.94 (+1.29%)
Volume$49.47K
Capitalization13.81B
CERO vs UTHR Comparison Chart in %
Loading...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERO vs. UTHR commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERO is a Buy and UTHR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (CERO: $7.86 vs. UTHR: $305.38)
Brand notoriety: CERO and UTHR are both not notable
CERO represents the Biotechnology, while UTHR is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CERO: 17% vs. UTHR: 118%
Market capitalization -- CERO: $10M vs. UTHR: $13.81B
CERO [@Biotechnology] is valued at $10M. UTHR’s [@Pharmaceuticals: Generic] market capitalization is $13.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $99.72B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.78B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERO’s FA Score shows that 1 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • CERO’s FA Score: 1 green, 4 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than CERO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERO’s TA Score shows that 2 TA indicator(s) are bullish while UTHR’s TA Score has 8 bullish TA indicator(s).

  • CERO’s TA Score: 2 bullish, 6 bearish.
  • UTHR’s TA Score: 8 bullish, 2 bearish.
According to our system of comparison, UTHR is a better buy in the short-term than CERO.

Price Growth

CERO (@Biotechnology) experienced а -10.68% price change this week, while UTHR (@Pharmaceuticals: Generic) price change was -2.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +17.87%, and the average quarterly price growth was +32.49%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.70%. For the same industry, the average monthly price growth was +10.88%, and the average quarterly price growth was +75.54%.

Reported Earning Dates

UTHR is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Generic (+3.70% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($13.8B) has a higher market cap than CERO($10M). UTHR YTD gains are higher at: -13.451 vs. CERO (-93.450). UTHR has higher annual earnings (EBITDA): 1.73B vs. CERO (-8.49M). UTHR has more cash in the bank: 3.05B vs. CERO (5.2M). CERO has less debt than UTHR: CERO (1.37M) vs UTHR (200M). UTHR has higher revenues than CERO: UTHR (3.08B) vs CERO (0).
CEROUTHRCERO / UTHR
Capitalization10M13.8B0%
EBITDA-8.49M1.73B-0%
Gain YTD-93.450-13.451695%
P/E RatioN/A11.91-
Revenue03.08B-
Total Cash5.2M3.05B0%
Total Debt1.37M200M1%
FUNDAMENTALS RATINGS
UTHR: Fundamental Ratings
UTHR
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CEROUTHR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
14%
Bearish Trend 2 days ago
59%
Momentum
ODDS (%)
Bearish Trend 2 days ago
42%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
26%
Bearish Trend 2 days ago
53%
Advances
ODDS (%)
Bullish Trend 20 days ago
55%
Bullish Trend 5 days ago
71%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 7 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
22%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBRN24.580.46
+1.89%
iShares Neuroscience and Healthcare ETF
FPF19.170.01
+0.05%
FIRST TRUST INTERMEDIATE DURATION PREFERRED & Income FUND
DEHP29.50-0.02
-0.07%
Dimensional Em Mkts High Prof ETF
CEPI40.36-0.14
-0.35%
Rex Crypto Equity Premium Income ETF
AGNG33.12-0.50
-1.50%
Global X Aging Population ETF

CERO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERO has been loosely correlated with UNCY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CERO jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERO
1D Price
Change %
CERO100%
-5.30%
UNCY - CERO
37%
Loosely correlated
+2.14%
UTHR - CERO
34%
Loosely correlated
-2.19%
ACXP - CERO
33%
Loosely correlated
+12.57%
BRTX - CERO
30%
Poorly correlated
-1.31%
LQDA - CERO
26%
Poorly correlated
-2.20%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with MNKD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then MNKD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-2.19%
MNKD - UTHR
38%
Loosely correlated
-5.11%
GERN - UTHR
37%
Loosely correlated
-2.74%
DAWN - UTHR
37%
Loosely correlated
-3.19%
ALNY - UTHR
36%
Loosely correlated
-2.36%
CBIO - UTHR
36%
Loosely correlated
-2.39%
More